Screener
Beta Bionics BBNX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other expense | (2) | (2) | (2) | (2) |
| Change in fair value of warrant liabilities | — | — | — | (12,450) |
| Total other income (expense), net | 2,175 | 3,003 | 4,551 | (7,011) |
| Net loss | $(23,403) | $(16,869) | $(45,298) | $(45,525) |
| Other comprehensive income (loss): | ||||
| Unrealized gain (loss) on short-term and long-term investments | (294) | (91) | (793) | 84 |
| Comprehensive loss | $(23,697) | $(16,960) | $(46,091) | $(45,441) |
| Net loss per share attributable to common stockholders, basic and diluted | $(0.53) | $(0.39) | $(1.02) | $(1.23) |
Item 1. Financial Statements.
FAQ
- What is Beta Bionics's net income?
- Beta Bionics (BBNX) reported net income of -$23.4M in Q2 2026.
- How has Beta Bionics's net income changed year-over-year?
- Beta Bionics's net income decreased by 38.7% year-over-year, from -$16.87M to -$23.4M.
- What is the long-term trend for Beta Bionics's net income?
- Over 2 years (2023 to 2025), Beta Bionics's net income has grown at a 28.8% compound annual growth rate (CAGR), from -$44.1M to -$73.2M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Beta Bionics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude